LEGN logo

Legend Biotech (LEGN) Cash and cash equivalents

annual cash & cash equivalents:

$286.75M-$990.96M(-77.56%)
December 31, 2024

Summary

  • As of today (June 29, 2025), LEGN annual cash & cash equivalents is $286.75 million, with the most recent change of -$990.96 million (-77.56%) on December 31, 2024.
  • During the last 3 years, LEGN annual cash & cash equivalents has fallen by -$402.19 million (-58.38%).
  • LEGN annual cash & cash equivalents is now -77.56% below its all-time high of $1.28 billion, reached on December 31, 2023.

Performance

LEGN Cash and cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLEGNbalance sheet metrics

quarterly cash & cash equivalents:

$441.70M+$154.95M(+54.04%)
March 31, 2025

Summary

  • As of today (June 29, 2025), LEGN quarterly cash & cash equivalents is $441.70 million, with the most recent change of +$154.95 million (+54.04%) on March 31, 2025.
  • Over the past year, LEGN quarterly cash & cash equivalents has dropped by -$455.87 million (-50.79%).
  • LEGN quarterly cash & cash equivalents is now -65.43% below its all-time high of $1.28 billion, reached on December 31, 2023.

Performance

LEGN quarterly cash & cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLEGNbalance sheet metrics

Cash and cash equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

LEGN Cash and cash equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-77.6%-50.8%
3 y3 years-58.4%+16.9%
5 y5 years+244.0%+161.7%

LEGN Cash and cash equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-77.6%at low-65.4%+119.5%
5 y5-year-77.6%+244.0%-65.4%+161.7%
alltimeall time-77.6%+244.0%-65.4%+429.9%

LEGN Cash and cash equivalents History

DateAnnualQuarterly
Mar 2025
-
$441.70M(+54.0%)
Dec 2024
$286.75M(-77.6%)
$286.75M(-37.6%)
Sep 2024
-
$459.28M(+128.2%)
Jun 2024
-
$201.25M(-77.6%)
Mar 2024
-
$897.57M(-29.8%)
Dec 2023
$1.28B(+62.6%)
$1.28B(+32.6%)
Sep 2023
-
$963.47M(-21.9%)
Jun 2023
-
$1.23B(+86.8%)
Mar 2023
-
$660.05M(-16.0%)
Dec 2022
$786.03M
$786.03M(+107.0%)
Jun 2022
-
$379.78M(+0.5%)
DateAnnualQuarterly
Mar 2022
-
$377.79M(-45.2%)
Dec 2021
$688.94M(+51.2%)
$688.94M(+103.6%)
Sep 2021
-
$338.33M(-30.7%)
Jun 2021
-
$488.21M(+18.4%)
Mar 2021
-
$412.30M(-9.5%)
Dec 2020
$455.69M(+446.6%)
$455.69M(+1.4%)
Sep 2020
-
$449.38M(-20.1%)
Jun 2020
-
$562.39M(+233.2%)
Mar 2020
-
$168.80M(+102.5%)
Dec 2019
$83.36M(-60.3%)
$83.36M
Dec 2018
$210.17M
-

FAQ

  • What is Legend Biotech annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Legend Biotech?
  • What is Legend Biotech annual cash & cash equivalents year-on-year change?
  • What is Legend Biotech quarterly cash & cash equivalents?
  • What is the all time high quarterly cash & cash equivalents for Legend Biotech?
  • What is Legend Biotech quarterly cash & cash equivalents year-on-year change?

What is Legend Biotech annual cash & cash equivalents?

The current annual cash & cash equivalents of LEGN is $286.75M

What is the all time high annual cash & cash equivalents for Legend Biotech?

Legend Biotech all-time high annual cash & cash equivalents is $1.28B

What is Legend Biotech annual cash & cash equivalents year-on-year change?

Over the past year, LEGN annual cash & cash equivalents has changed by -$990.96M (-77.56%)

What is Legend Biotech quarterly cash & cash equivalents?

The current quarterly cash & cash equivalents of LEGN is $441.70M

What is the all time high quarterly cash & cash equivalents for Legend Biotech?

Legend Biotech all-time high quarterly cash & cash equivalents is $1.28B

What is Legend Biotech quarterly cash & cash equivalents year-on-year change?

Over the past year, LEGN quarterly cash & cash equivalents has changed by -$455.87M (-50.79%)
On this page